http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32526514

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural
endingPage 495
issn 1556-0864
issueIdentifier 3
pageRange 485-495
publicationName Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage 485
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_336dcaa4aeada1e5e5cd289f15c409ee
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ae90c8435cdd1d8ca3c7b4a8a049d815
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3df4c56ffadec6b5cb66ba7d20aae270
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_62590e6028615744a54e76f45bbc2657
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2272fe661ec9002a493173c42c4022a6
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1c1983168e9688d0976ddc3d312c64b0
bibliographicCitation Siegfried JM, Gubish CT, Rothstein ME, Henry C, Stabile LP. Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2012 Mar;7(3):485–95. doi: 10.1097/jto.0b013e31824177ea.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_472729035f9ece5bb427d86db330b7f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee3cf240a546f8970e527bcb9acdd08b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70385ddc97d7a4621a24a6f6bcd99422
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fa90d0ceb7830e7690050960d721ef6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b189c3b6042997a817308d9d12f4b1c2
date 201203
identifier https://pubmed.ncbi.nlm.nih.gov/22258476
https://pubmed.ncbi.nlm.nih.gov/PMC3288546
https://doi.org/10.1097/jto.0b013e31824177ea
isPartOf https://portal.issn.org/resource/ISSN/1556-0864
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer
discusses http://id.nlm.nih.gov/mesh/M0328117
http://id.nlm.nih.gov/mesh/M0007795
http://id.nlm.nih.gov/mesh/M0421253
http://id.nlm.nih.gov/mesh/M0397101
http://id.nlm.nih.gov/mesh/M0356369
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0593322
http://id.nlm.nih.gov/mesh/M0007772
http://id.nlm.nih.gov/mesh/M0016885
http://id.nlm.nih.gov/mesh/M0017888
http://id.nlm.nih.gov/mesh/M0202877
http://id.nlm.nih.gov/mesh/M0019167
http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D047428Q000494
http://id.nlm.nih.gov/mesh/D002289Q000473
http://id.nlm.nih.gov/mesh/D020847Q000494
http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D004958Q000031
http://id.nlm.nih.gov/mesh/D010880Q000494
http://id.nlm.nih.gov/mesh/D011505Q000037
http://id.nlm.nih.gov/mesh/D011799Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D007124
http://id.nlm.nih.gov/mesh/D040321Q000235
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D049109Q000187
http://id.nlm.nih.gov/mesh/D014407
http://id.nlm.nih.gov/mesh/D004797
http://id.nlm.nih.gov/mesh/D040321Q000037
http://id.nlm.nih.gov/mesh/D000971
http://id.nlm.nih.gov/mesh/D040321Q000378
http://id.nlm.nih.gov/mesh/D017209Q000187
http://id.nlm.nih.gov/mesh/D066246Q000378
http://id.nlm.nih.gov/mesh/D066246Q000235
http://id.nlm.nih.gov/mesh/D004967Q000494
http://id.nlm.nih.gov/mesh/D000077267
http://id.nlm.nih.gov/mesh/D005455
http://id.nlm.nih.gov/mesh/D004958Q000494
http://id.nlm.nih.gov/mesh/D004357
http://id.nlm.nih.gov/mesh/D002289Q000378
http://id.nlm.nih.gov/mesh/D015153
http://id.nlm.nih.gov/mesh/D042461Q000378
http://id.nlm.nih.gov/mesh/D042461Q000235
http://id.nlm.nih.gov/mesh/D042461Q000037
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D016513
http://id.nlm.nih.gov/mesh/D008175Q000473
http://id.nlm.nih.gov/mesh/D008175Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D060888
http://id.nlm.nih.gov/mesh/D012333Q000235
http://id.nlm.nih.gov/mesh/D008175Q000188
http://id.nlm.nih.gov/mesh/D066246Q000037
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5a10bff44321e2f4009b2e7bc13c3771
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104741
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247533733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136284721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129506098

Total number of triples: 97.